SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 205.970.0%10:48 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tonyt who wrote (19803)5/5/1998 10:44:00 PM
From: N  Read Replies (1) of 32384
 
Mergers indeed! And off topic...

Thanks for the update. I had talked to a chemist at Merck about Neurex' morphine substitute and was told (SNX111 or not?) that it was a lolly pop with duragesic (duragesic is the brand name of the narcotic I've forgotten -- my charge was totally 'out' for three days on lowest dose and I stayed up straight during that time to be on watch.) If so, not a major break through in my fondest hopes. Wonder how working on a lollypop is going to be any easier for a chronical ill person than taking oral morphine. And none of the other opioid side affects that make life so tough were addressed either. Hope SNX11 is not duragesic, but something better.

N.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext